Lipid-activated nuclear receptors: From gene transcription to the control of cellular metabolism

European Journal of Lipid Science and Technology

Volumn 106, Issue 7, 2004, Pages 432-450

  Crestani, Maurizio ^a   Mitro, Nico ^a   De Fabiani, Emma ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Glucose metabolism; Lipid metabolism; Nuclear receptors; Transcription regulation

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; FATTY ACID DERIVATIVE; LIPID; OXYSTEROL;

CELL FUNCTION; CELL METABOLISM; CHEMICAL COMPOSITION; ENVIRONMENTAL FACTOR; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR BIOLOGY; NUTRITION; REVIEW; TRANSCRIPTION INITIATION;

EID: 4143106645     PISSN: 14387697     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejlt.200300936     Document Type: Review

References (201)

1. A. Chawla, J. J. Repa, R. M. Evans, D. J. Mangelsdorf: Nuclear receptors and lipid physiology: opening the X-files. Science 294 (2001) 1866-1870.
2. A. Horlein, A. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. Glass: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377 (1995) 397-404.
3. J. D. Chen, R. M. Evans: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 (1995) 454-457.
4. M. Hadzopoulou-Cladaras, E. Kistanova, C. Evagelopoulou, S. Zeng, C. Cladaras, J. A. Ladias: Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem. 272 (1997) 539-550.
5. M. D. Ruse, Jr., M. L. Privalsky, F. M. Sladek:, Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4α1: Modulation by the F-domain. Mol. Cell. Biol. 22 (2002) 1626-1638.
6. B. D. Darimont, R. L. Wagner, J. W. Apriletti, M. R. Stallcup, P. J. Kushner, J. D. Baxter, R. J. Fletterick, K. R. Yamamoto: Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12 (1998) 3343-3356.
7. R. Kurokawa, M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, C. K. Glass: Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377 (1995) 451-454.
8. C. E Juge-Aubry, E. Hammar, C. Siegrist-Kaiser, A. Pernin, A. Takeshita, W. W. Chin, A. G. Burger, C. A. Meier: Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent transactivating domain. J. Biol. Chem. 274 (1999) 10505-10510.
9. E. Ktistaki, T. Ktistaki, E. Papadogeorgaki, I. Talianidis: Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9876-9880.
10. E. Hu, J. B. Kim, P. Sarraf, B. M. Spiegelman: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274 (1996) 2100-2103.
11. E. Soutoglou, N. Katrakili, I. Talianidis: Acetylation regulates transcription factor activity at multiple levels. Mol. Cell 5 (2000) 745-751.
12. M. G. Rosenfeld, C. K. Glass: Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 276 (2001) 36865-36868.
13. O. Hermanson, C. Glass, M. Rosenfeld: Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13 (2002) 55-60.
14. K. Struhl: Fundamentally different logic of gene regulation in eukaryotes and prokaryotes. Cell 98 (1999) 1-4.
15. T. Jenuwein, C. D. Allis: Translating the histone code. Science 293 (2001) 1074-1080.
16. R. Apfel, D. Benbrook, E. Lernhardt, M. A. Ortiz, G. Salbert, M. Pfahl: A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 14 (1994) 7025-7035.
17. C. Song, J. M. Kokontis, R. A. Hipaka, S. Liao: Ubiquitous receptor: A receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 10809-10813.
18. P. J. Willy, K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, D. J. Mangelsdorf: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9 (1995) 1033-1045.
19. P. J. Willy, D. J. Mangelsdorf: Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 11 (1997) 289-298.
20. X. Hu, S. Li, J. Wu, C. Xia, D. S. Lala: Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 17 (2003) 1019-1026.
21. B. L. Wagner, A. F. Valledor, G. Shao, C. L. Daige, E. D. Bischoff, M. Petrowski, K. Jepsen, S. H. Baek, R. A. Heyman, M. G. Rosenfeld, I. G. Schulman, C. K. Glass: Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell. Biol. 23 (2003) 5780-5789.
22. X. Fu, J. G. Menke, Y. Chen, G. Zhou, K. L. MacNaul, S. D. Wright, C. P. Sparrow, E. G. Lund: 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001) 38378-38387.
23. J. Collins, A. Fivush, M. Watson, C. Galardi, M. Lewis, L. Moore, D. Parks, J. Wilson, T. Tippin, J. Binz, K. Plunket, D. Morgan, E. Beaudet, K. Whitney, S. Kliewer, T. Willson: Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J. Med. Chem. 45 (2002) 1963-1966.
24. C. Song, S. Liao: Cholestenoic acid is a naturally occurring ligand for liver X receptor α. Endocrinology 141 (2000) 4180-4184.
25. M. Nitta, S. Ku, C. Brown, A. Y. Okamoto, B. Shan: CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6660-6665.
26. T. T. Lu, M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, D. J. Mangelsdorf: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6 (2000) 507-515.
27. Y. Luo, C.-P. Liang, A. R. Tall: The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J. Biol. Chem. 276 (2001) 24767-24773.
28. C. Brendel, K. Schoonjans, O. A. Botrugno, E. Treuter, J. Auwerx: The small heterodimer partner interacts with the liver X receptor α and represses its transcriptional activity. Mol. Endocrinol. 16 (2002) 2065-2076.
29. S. Alberti, K. Steffensen, J. Gustafsson: Structural characterisation of the mouse nuclear oxysterol receptor genes LXRα and LXRβ. Gene 243 (2000) 93-103.
30. S. Alberti, G. Schuster, P. Parini, D. Feltkamp, U. Diczfalusy, M. Rudling, B. Angelin, I. Bjorkhem, S. Pettersson, J. Gustafsson: Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRb-deficient mice. J. Clin. Invest. 107 (2001) 565-573.
31. R. K. Tangirala, E. D. Bischoff, S. B. Joseph, B. L. Wagner, R. Walczak, B. A. Laffitte, C. L. Daige, D. Thomas, R. A. Heyman, D. J. Mangelsdorf, X. Wang, A. J. Lusis, P. Tontonoz, I. G. Schulman: Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11896-11901.
32. B. A. Janowski, P. J. Willy, T. R. Devi, J. R. Falk, D. J. Mangelsdorf: An oxysterol signaling pathway mediated by the nuclear receptor LXRα. Nature 383 (1996) 728-731.
33. B. M. Forman, B. Ruan, J. Chen, G. J. Schroepfer, R. M. Evans: The orphan nuclear receptor LXRa is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10588-10593.
34. J. M. Lehmann, S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J.-L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, T. M. Willson: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997) 3137-3140.
35. B. A. Janowski, M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, D. J. Mangelsdorf: Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 266-271.
36. J. Ou, H. Tu, B. Shan, A. Luk, R. A. DeBose-Boyd, Y. Bashmakov, J. L. Goldstein, M. S. Brown: Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6027-6032.
37. T. Yoshikawa, H. Shimano, N. Yahagi, T. Ide, M. Amemiya-Kudo, T. Matsuzaka, M. Nakakuki, S. Tomita, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, A. Takahashi, H. Sone, J.-I. Osuga, T. Gotoda, S. Ishibashi, N. Yamada: Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 277 (2002) 1705-1711.
38. J. R. Schultz, H. Tu, A. Luk, J. J. Repa, J. C. Medina, L. Li, S. Schwendner, S. Wang, M. Thoolen, D. J. Mangelsdorf, K. D. Lustig, B. Shan: Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838.
39. P. Costet, Y. Luo, N. Wang, A. R. Tall: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275 (2000) 28240-28245.
40. K. Schwartz, R. M. Lawn, D. P. Wade: ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 274 (2000) 794-802.
41. A. Venkateswaran, B. A. Laffitte, S. B. Joseph, P. A. Mak, D. C. Wilpitz, P. A. Edwards, P. Tontonoz: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12097-12102.
42. A. Chawla, W. A. Boisvert, C. H. Lee, B. A. Laffitte, Y. Barak, S. B. Joseph, D. Liao, L. Nagy, P. A. Edwards, L. K. Curtiss, R. M. Evans, P. Tontonoz: A PPAR γ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7 (2001) 161-171.
43. G. Chinetti, S. Lestavel, V. Bocher, A. T. Remaley, B. Neve, I. P. Torra, E. Teissier, A. Minnich, M. Jaye, N. Duverger, H. B. Brewer, J.-C. Fruchart, V. Clavey, B. Staels: PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Med. 7 (2001) 53-58.
44. K. A. Tobin, H. H. Steineger, S. Alberti, O. Spydevold, J. Auwerx, J. A. Gustafsson, H. I. Nebb: Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-α. Mol. Endocrinol. 14 (2000) 741-752.
45. T. E. Akiyama, S. Sakai, G. Lambert, C. J. Nicol, K. Matsusue, S. Pimprale, Y.-H. Lee, M. Ricote, C. K. Glass, H. B. Brewer, Jr., F. J. Gonzalez: Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 22 (2002) 2607-2619.
46. A. Venkateswaran, J. J. Repa, J.-M. A. Lobaccaro, A. Bronson, D. J. Mangelsdorf, P. A. Edwards: Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275 (2000) 14700-14707.
47. B. A. Laffitte, J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, P. Tontonoz: LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 507-512.
48. P. A. Mak, B. A. Laffitte, C. Desrumaux, S. B. Joseph, L. K. Curtiss, D. J. Mangelsdorf, P. Tontonoz, P. A. Edwards: Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors α and β. J. Biol. Chem. 277 (2002) 31900-31908.
49. Y. Luo, A. R. Tall: Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest. 105 (2000) 513-520.
50. G. Cao, T. P. Beyer, X. P. Yang, R. J. Schmidt, Y. Zhang, W. R. Bensch, R. F. Kauffman, H. Gao, T. P. Ryan, Y. Liang, P. I. Eacho, X.-C. Jiang: Phospholipid transfer protein is regulated by liver X receptors in vivo. J. Biol. Chem. 277 (2002) 39561-39565.
51. B. A. Laffitte, S. B. Joseph, M. Chen, A. Castrillo, J. Repa, D. Wilpitz, D. Mangelsdorf, P. Tontonoz: The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 23 (2003) 2182-2191.
52. S. Acton, A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, M. Krieger: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520.
53. L. Malerod, L. K. Juvet, A. Hanssen-Bauer, W. Eskild, T. Berg: Oxysterol-activated LXRa/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem. Biophys. Res. Commun. 299 (2002) 916-923.
54. Gupta, Pandak, Hylemon: LXRα is the dominant regulator of CYP7A1 transcription. Biochem. Biophys. Res. Commun. 293 (2002) 338-343.
55. J. Chiang, R. Kimmel, D. Stroup: Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα). Gene 262 (2001) 257-265.
56. B. Goodwin, M. A. Watson, H. Kim, J. Miao, J. K. Kemper, S. A. Kliewer: Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-α. Mol. Endocrinol. 17 (2003) 386-394.
57. J. Y. Chen, B. Levy-Wilson, S. Goodart, A. D. Cooper: Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J. Biol. Chem. 277 (2002) 42588-42595.
58. T. Plosch, T. Kok, V. W. Bloks, M. J. Smit, R. Havinga, G. Chimini, A. K. Groen, F. Kuipers: Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J. Biol. Chem. 277 (2002) 33870-33877.
59. L. Yu, J. York, K. von Bergmann, D. Lutjohann, J. C. Cohen, H. H. Hobbs: Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J. Biol. Chem. 278 (2003) 15565-15570.
60. M. S. Brown, J. L. Goldstein: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340.
61. J. J. Repa, G. Liang, J. Ou, Y. Bashmakov, J. M. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, D. J. Mangelsdorf: Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14 (2000) 2819-2830.
62. R. A. DeBose-Boyd, J. Ou, J. L. Goldstein, M. S. Brown: Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1477-1482.
63. T. Yoshikawa, H. Shimano, M. Amemiya-Kudo, N. Yahagi, A. H. Hasty, T. Matsuzaka, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, J.-I. Osuga, K. Harada, T. Gotoda, S. Kimura, S. Ishibashi, N. Yamada: Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 21 (2001) 2991-3000.
64. G. Liang, J. Yang, J. D. Norton, R. E. Hammer, J. L. Goldstein, M. S. Brown: Diminished hepatic response to fasting/ refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 (2002) 9520-9528.
65. S. B. Joseph, B. A. Laffitte, P. H. Patel, M. A. Watson, K. E. Matsukuma, R. Walczak, J. L. Collins, T. F. Osborne, P. Tontonoz: Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277 (2002) 11019-11025.
66. A. Grefhorst, B. M. Elzinga, P. J. Voshol, T. Plosch, T. Kok, V. W. Bloks, F. H. van der Sluijs, L. M. Havekes, J. A. Romijn, H. J. Verkade, F. Kuipers: Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277 (2002) 34182-34190.
67. L. K. Juvet, S. M. Andresen, G. U. Schuster, K. T. Daten, K. A. R. Tobin, K. Hollung, F. Haugen, S. Jacinto, S. M. Ulven, K. Bamberg, J.-A. Gustafsson, H. I. Nebb: On the role of liver X receptors in lipid accumulation in adipocytes. Mol. Endocrinol. 17 (2003) 172-182.
68. G. Cao, Y. Liang, C. L. Broderick, B. A. Oldham, T. P. Beyer, R. J. Schmidt, Y. Zhang, K. R. Stayrook, C. Suen, K. A. Otto, A. R. Miller, J. Dai, P. Foxworthy, H. Gao, T. P. Ryan, X.-C. Jiang, T. P. Burris, P. I. Eacho, G. J. Etgen: Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 278 (2003) 1131-1136.
69. G. E. O. Muscat, B. L. Wagner, J. Hou, R. K. Tangirala, E. D. Bischoff, P. Rohde, M. Petrowski, J. Li, G. Shao, G. Macondray, I. G. Schulman: Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J. Biol. Chem. 277 (2002) 40722-40728.
70. T. M. Stulnig, U. Oppermann, K. R. Steffensen, G. U. Schuster, J.-A. Gustafsson: Liver X receptors downregulate 11β-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 51 (2002) 2426-2433.
71. B. A. Laffitte, L. C. Chao, J. Li, R. Walczak, S. Hummasti, S. B. Joseph, A. Castrillo, D. C. Wilpitz, D. J. Mangelsdorf, J. L. Collins, E. Saez, P. Tontonoz: Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5419-5424.
72. K. D. Whitney, M. A. Watson, B. Goodwin, C. M. Galardi, J. M. Maglich, J. G. Wilson, T. M. Willson, J. L. Collins, S. A. Kliewer: Liver X Receptor (LXR) Regulation of the LXRα gene in human macrophages. J. Biol. Chem. 276 (2001) 43509-43515.
73. B. A. Laffitte, S. B. Joseph, R. Walczak, L. Pei, D. C. Wilpitz, J. L. Collins, P. Tontonoz: Autoregulation of the human liver X receptor α promoter. Mol. Cell. Biol. 21 (2001) 7558-7568.
74. T. Yoshikawa, T. Ide, H. Shimano, N. Yahagi, M. Amemiya-Kudo, T. Matsuzaka, S. Yatoh, T. Kitamine, H. Okazaki, Y. Tamura, M. Sekiya, A. Takahashi, A. H. Hasty, R. Sato, H. Sone, J.-I. Osuga, S. Ishibashi, N. Yamada: Cross-talk between peroxisome proliferator-activated receptor (PPAR) α and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol. Endocrinol. 17 (2003) 1240-1254.
75. T. Ide, H. Shimano, T. Yoshikawa, N. Yahagi, M. Amemiya-Kudo, T. Matsuzaka, M. Nakakuki, S. Yatoh, Y. Iizuka, S, Tomita, K. Ohashi, A. Takahashi, H. Sone, T. Gotoda, J.-I. Osuga, S. Ishibashi, N. Yamada: Cross-talk between peroxisome proliferator-activated receptor (PPAR) α and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol. Endocrinol. 17 (2003) 1255-1267.
76. K. S. Miyata, S. E. McCaw, H. V. Patel, R. A. Rachubinski, J. P. Capone: The orphan nuclear hormone receptor LXR α interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271 (1996) 9189-9192.
77. A. Hihi, L. Michalik, W. Wahli: PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol. Life Sci. 59 (2002) 790-798.
78. H. E. Xu, M. H. Lambert, V. G. Montana, K. D. Plunket, L. B. Moore, J. L. Collins, J. A. Oplinger, S. A. Kliewer, R. T. Gampe, Jr., D. D. McKee, J. T. Moore, T. M. Willson: Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13919-13924.
79. I. Issemann, S. Green: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650.
80. M. Gottlicher, E. Widmark, Q. Li, J. Gustafsson: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4653-4657.
81. G. Krey, O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, W. Wahli: Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997) 779-791.
82. S. A. Kliewer, S. S. Sundseth, S. A. Jones, P. J. Brown, G. B. Wisely, C. S. Koble, P. Devchand, W. Wahli, T. M. Willison, J. M. Lenhard, J. M. Lehmann: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptor α and β. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4318-4323.
83. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83 (1995) 803-812.
84. S. A. Kliewer, J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, J. M. Lehmann: A prostaglandin J2 metabolite binds peroxisome proliferator- activated receptor γ and promotes adipocyte differentiation. Cell 83 (1995) 813-819.
85. L. Nagy, P. Tontonoz, J. G. Alvarez, H. Chen, R. M. Evans: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93 (1998) 229-240.
86. J. R. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, S. A. Kliewer: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270 (1995) 12953-12956.
87. S. Mudaliar, R. Henry: New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers. Annu. Rev. Med. 52 (2001) 239-257.
88. J. Berger, M. D. Leibowitz, T. W. Doebber, A. Elbrecht, B. Zhang, G. Zhou, C. Biswas, C. A. Cullinan, N. S. Hayes, Y. Li, M. Tanen, J. Ventre, M. S. Wu, G. D. Berger, R. Mosley, R. Marquis, C. Santini, S. P. Sahoo, R. L. Tolman, R. G. Smith, D. E. Moller: Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects. J. Biol. Chem. 274 (1999) 6718-6725.
89. W. R. Oliver, Jr., J. L. Shenk, M. R. Snaith, C. S. Russell, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Winegar, M. L. Sznaidman, M. H. Lambert, H. E. Xu, D. D. Sternbach, S. A. Kliewer, B. C. Hansen, T. M. Willson: A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5306-5311.
90. M. Leibowitz, C. Fievet, N. Hennuyer, J. Peinado-Onsurbe, H. Duez, J. Bergera, C. Cullinan, C. Sparrow, J. Baffic, G. Berger, C. Santini, R. Marquis, R. Tolman, R. Smith, D. Moller, J. Auwerx: Activation of PPARδ alters lipid metabolism in db/db mice. FEBS Lett. 473 (2000) 333-336.
91. D. Auboeuf, H. Vidal: The use of reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal. Biochem. 245 (1997) 141-148.
92. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, W. Wahli: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137 (1996) 354-366.
93. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, I. Torra, P. Delerive, A. Fadel, G. Chinetti, J. Fruchart, J. Najib, J. Maclouf, A. Tedgui: Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393 (1998) 790-793.
94. I. Inoue, K. Shino, S. Noji, T. Awata, S. Katayama: Expression of peroxisome proliferator-activated receptor α (PPAR α) in primary cultures of human vascular endothelial cells. Biochem. Biophys. Res. Commun. 246 (1998) 370-374.
95. G. Chinetti, S. Griglio, M. Antonucci, I. P. Torra, P. Delerive, Z. Majd, J.-C. Fruchart, J. Chapman, J. Najib, B. Staels: Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273 (1998) 25573-25580.
96. N. Marx, P. Libby, J. Plutzky: Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk? J. Cardiovasc. Risk 8 (2001) 203-210.
97. K. Motojima, P. Passilly, J. M. Peters, F. J. Gonzalez, N. Latruffe: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. J. Biol. Chem. 273 (1998) 16710-16714.
98. G. Martin, K. Schoonjans, A.-M. Lefebvre, B. Staels, J. Auwerx: Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators. J. Biol. Chem. 272 (1997) 28210-28217.
99. J. D. Tugwood, I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, S. Green: The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11 (1992) 433-439.
100. B. Zhang, S. L. Marcus, K. S. Miyata, S. Subramani, J. P. Capone, R. A. Rachubinski: Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem. 268 (1993) 12939-12945.
101. K. Schoonjans, M. Watanabe, H. Suzuki, A. Mahfoudi, G. Krey, W. Wahli, P. Grimaldi, B. Staels, T. Yamamoto, J. Auwerx: Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C Promoter. J. Biol. Chem. 270 (1995) 19269-19276.
102. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, W. Wahli: Peroxisome proliferator-activated receptor mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498.
103. T. C. Leone, C. J. Weinheimer, D. P. Kelly: A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7473-7478.
104. T. C. Aldridge, J. D. Tugwood, S. Green: Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306 (1995) 473-479.
105. S. Lee, T. Pineau, J. Drago, E. Lee, J. Owens, D. Kroetz, P. Fernandez-Salguero, H. Westphal, F. Gonzalez: Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisime proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022.
106. N. Vu-Dac, S. Chopin-Delannoy, P. Gervois, E. Bonnelye, G. Martin, J.-C. Fruchart, V. Laudet, B. Staels: The nuclear receptors peroxisome proliferator-activated receptoroc and Rev-erbα mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem. 273 (1998) 25713-25720.
107. N. Vu-Dac, K. Schoonjans, V. Kosykh, J. Dallongeville, J. C. Fruchart, B. Staels, J. Auwerx: Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96 (1995) 741-750.
108. K. Schoonjans, B. Staels, J. Auwerx: The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302 (1996) 93-109.
109. K. Schoonjans, J. Peinado-Onsurbe, A. Lefebvre, R. Heyman, M. Briggs, S. Deeb, B. Staels, J. Auwerx: PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15 (1996) 5336-5348.
110. G. Chinetti, F. G. Gbaguidi, S. Griglio, Z. Mallat, M. Antonucci, P. Poulain, J. Chapman, J.-C. Fruchart, A. Tedgui, J. Najib-Fruchart, B. Staels: CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101 (2000) 2411-2417.
111. D. M. Muoio, P. S. MacLean, D. B. Lang, S. Li, J. A. Houmard, J. M. Way, D. A. Winegar, J. C. Corton, G. L. Dohm, W. E. Kraus: Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Evidence for compensatory regulation by PPARδ. J. Biol. Chem. 277 (2002) 26089-26097.
112. Y. Wang, C. Lee, S. Tiep, R. Yu, J. Ham, H. Kang, R. Evans: Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113 (2003) 159-170.
113. S. Luquet, J. Lopez-Soriano, D. Holst, A. Fredenrich, J. Melki, M. Rassoulzadegan, P. A. Grimaldi: Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB J. 17 (2003) 2299-2301.
114. L. Michalik, B. Desvergne, N. S. Tan, S. Basu-Modak, P. Escher, J. Rieusset, J. M. Peters, G. Kaya, F. J. Gonzalez, J. Zakany, D. Metzger, P. Chambon, D. Duboule, W. Wahli: Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice. J. Cell Biol. 154 (2001) 799-814.
115. L. Michalik, B. Desvergne, C. Dreyer, M. Gavillet, R. N. Laurini, W. Wahli: PPAR expression and function during vertebrate development. Int. J. Dev. Biol. 46 (2002) 105-114.
116. J. M. Peters, S. S. T. Lee, W. Li, J. M. Ward, O. Gavrilova, C. Everett, M. L. Reitman, L. D. Hudson, F. J. Gonzalez: Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β/δ. Mol. Cell. Biol. 20 (2000) 5119-5128.
117. Y. Barak, D. Liao, W. He, E. S. Ong, M. C. Nelson, J. M. Olefsky, R. Boland, R. M. Evans: Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 303-308.
118. A. Chawla, C.-H. Lee, Y. Barak, W. He, J. Rosenfeld, D. Liao, J. Han, H. Kang, R. M. Evans: PPARδ is a very low-density lipoprotein sensor in macrophages. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1268-1273.
119. L. Fajas, D. Auboeuf, E. Raspe, K. Schoonjans, A.-M. Lefebvre, R. Saladin, J. Najib, M. Laville, J.-C. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M. R. Briggs, B. Staels, H. Vidal, J. Auwerx: The organization, promoter analysis, and expression of the human PPARγ Gene. J. Biol. Chem. 272 (1997) 18779-18789.
120. L. Fajas, J. Fruchart, J. Auwerx: PPARgamma3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Lett. 438 (1998) 55-60.
121. L. Fajas, M. B. Debril, J. Auwerx: Peroxisome proliferator-activated receptor-γ: from adipogenesis to carcinogenesis. J. Mol. Endocrinol. 27 (2001) 1-9.
122. P. Tontonoz, E. Hu, B. Spiegelman: Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156.
123. E. D. Rosen, C.-H. Hsu, X. Wang, S. Sakai, M. W. Freeman, F. J. Gonzalez, B. M. Spiegelman: C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 16 (2002) 22-26.
124. C. B. Kallen, M. A. Lazar: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5793-5796.
125. P. De Vos, A.-M. Lefebvre, S. G. Miller, M. Guerre-Millo, K. Wong, R. Saladin, L. G. Hamann, B. Staels, M. R. Briggs, J. Auwerx: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J. Clin. Invest. 98 (1996) 1004-1009.
126. L. J. Kelly, P. P. Vicario, G. M. Thompson, M. R. Candelore, T. W. Doebber, J. Ventre, M. S. Wu, R. Meurer, M. J. Forrest, M. W. Conner, M. A. Cascieri, D. E. Moller: Peroxisome proliferator-activated receptors γ and α mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) Gene Expression. Endocrinology 139 (1998) 4920-4927.
127. A. W. Norris, L. Chen, S. J. Fisher, I. Szanto, M. Ristow, A. C. Jozsi, M. F. Hirshman, E. D. Rosen, L. J. Goodyear, F. J. Gonzalez, B. M. Spiegelman, C. R. Kahn: Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J. Clin. Invest. 112 (2003) 608-618.
128. J. M. Way, W. W. Harrington, K. K. Brown, W. K. Gottschalk, S. S. Sundseth, T. A. Mansfield, R. K. Ramachandran, T. M. Willson, S. A. Kliewer: Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142 (2001) 1269-1277.
129. B. M. Forman, E. Goode, J. Chen, A. E. Oro, D. J. Bradley, T. Perlmann, D. J. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, R. M. Evans, C. Weinberger: Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81 (1995) 687-693.
130. W. Seol, H. Choi, D. Moore: Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9 (1995) 72-85.
131. J. J. Repa, S. D. Turley, J.-M. A. Lobaccaro, J. Medina, L. Li, K.
132. A. Kassam, B. Miao, P. R. Young, R. Mukherjee: Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J. Biol. Chem. 278 (2003) 10028-10032.
133. M. Downes, M. Verdecia, A. Roecker, R. Hughes, J. Hogenesch, H. Kast-Woelbern, M. Bowman, J. Ferrer, A. Anisfeld, P. Edwards, J. Rosenfeld, J. Alvarez, J. Noel, K. Nicolaou, R. Evans: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell 11 (2003) 1079-1092.
134. X. Prieur, H. Coste, J. C. Rodriguez: The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response element. J. Biol. Chem. 278 (2003) 25468-25480.
135. T. Claudel, E. Sturm, H. Duez, I. P. Torra, A. Sirvent, V. Kosykh, J.-C. Fruchart, J. Dallongeville, D. W. Hum, F. Kuipers, B. Staels: Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J. Clin. Invest. 109 (2002) 961-971.
136. T. Claudel, Y. Inoue, O. Barbier, D. Duran-Sandoval, V. Kosykh, J. Fruchart, J. Fruchart, F. Gonzalez, B. Staels: Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125 (2003) 544-555.
137. H. Wang, J. Chen, K. Hollister, L. C. Sowers, B. M. Forman: Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3 (1999) 543-553.
138. D. J. Parks, S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, J. M. Lehmann: Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (1999) 1365-1368.
139. M. Makishima, A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, B. Shan: Identification of a nuclear receptor for bile acids. Science 284 (1999) 1362-1365.
140. C. J. Sinai, M. Tohkin, M. Miyata, J. M. Ward, G. Lambert, F. J. Gonzalez: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102 (2000) 731-744.
141. J. Yu, J.-L. Lo, L. Huang, A. Zhao, E. Metzger, A. Adams, P. T. Meinke, S. D. Wright, J. Cui: Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J. Biol. Chem. 277 (2002) 31441-31447.
142. X. Cui, H. Kawashima, T. B. Barclay, J. M. Peters, F. J. Gonzalez, E. T. Morgan, H. W. Strobel: Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor α-deficient mice upon lipopolysaccharide and clofibrate challenges. J. Pharmacol. Exp. Ther. 296 (2001) 542-550.
143. P. R. Maloney, D. J. Parks, C. Haffner, D., A. M. Fivush, G. Chandra, K. D. Plunket, K. L. Creech, L. B. Moore, J. G. Wilson, M. Lewis, C., S. A. Jones, T. M. Willson: Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med. Chem. 43 (2000) 2971-2974.
144. N. L. Urizar, A. B. Liverman, D. N. T. Dodds, F. V. Silva, P. Ordentlich, Y. Yan, F. J. Gonzalez, R. A. Heyman, D. J. Mangelsdorf, D. D. Moore: A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296 (2002) 1703-1706.
145. J. Wu, C. Xia, J. Meier, S. Li, X. Hu, D. S. Lala: The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Mol. Endocrinol. 16 (2002) 1590-1597.
146. J. Y. L. Chiang, R. Kimmel, C. Weinberger, D. Stroup: Farnesoid X receptor responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275 (2000) 10918-10924.
147. J. Goodrich, R. Carpenter, E. S. Coen: A common gene regulates pigmentation pattern in diverse plant species. Cell 68 (1992) 955-964.
148. J. A. Holt, G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, D. Y. Wang, T. A. Mansfield, S. A. Kliewer, B. Goodwin, S. A. Jones: Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17 (2003) 1581-1591.
149. E. De Fabiani, N. Mitro, A. C. Anzulovich, A. Pinelli, G. Galli, M. Crestani: The negative effects of bile acids and tumor necrosis factor-α on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatocyte nuclear factor-4. A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J. Biol. Chem. 276 (2001) 30708-30716.
150. L. Wang, Y Lee, D. Bundman, Y. Han, S. Thevananther, C. Kim, S. Chua, P. Wei, R. Heyman, M. Karin, D. Moore: Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2 (2002) 721-731.
151. E. De Fabiani, N. Mitro, F. Gilardi, D. Caruso, G. Galli, M. Crestani: Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed Cycle. J. Biol. Chem. 278 (2003) 39124-39132.
152. G. Xu, L.-X. Pan, S. K. Erickson, B. M. Forman, B. L. Shneider, M. Ananthanarayanan, X. Li, S. Shefer, N. Balasubramanian, L. Ma, H. Asaoka, S. R. Lear, L. B. Nguyen, I. Dussault, F. J. Suchy, G. S. Tint, G. Salen: Removal of the bile acid pool upregulates cholesterol 7α-hydroxylase by deactivating FXR in rabbits. J. Lipid Res. 43 (2002) 45-50.
153. G. Xu, L.-X. Pan, H. Li, B. M. Forman, S. K. Erickson, S. Shefer, J. Bollineni, A. K. Batta, J. Christie, T.-H. Wang, J. Michel, S. Yang, R. Tsai, L. Lai, K. Shimada, G. S. Tint, G. Salen: Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J. Biol. Chem. 277 (2002) 50491-50496.
154. J. Li-Hawkins, M. Gafvels, M. Olin, E. G. Lund, U. Andersson, G. Schuster, I. Bjorkhem, D. W. Russell, G. Eggertsen: Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J. Clin. Invest. 110 (2002) 1191-1200.
155. L. A. Denson, E. Sturm, W. Echevarria, T. L. Zimmerman, M. Makishima, D. J. Mangelsdorf, S. J. Karpen: The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121 (2001) 140-147.
156. M. Ananthanarayanan, N. Balasubramanian, M. Makishima, D. J. Mangelsdorf, F. J. Suchy: Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276 (2001) 28857-28865.
157. T. Gerloff, A. Geier, I. Roots, P. J. Meier, C. Gartung: Functional analysis of the rat bile salt export pump gene promoter. Eur. J. Biochem. 269 (2002) 3495-3503.
158. J. Grober, I. Zaghini, H. Fujii, S. A. Jones, S. A. Kliewer, T. M. Willson, T. Ono, P. Besnard: Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 274 (1999) 29749-29754.
159. G. Lambert, M. J. A. Amar, G. Guo, H. B. Brewer, Jr., F. J. Gonzalez, C. J. Sinal: The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J. Biol. Chem. 278 (2003) 2563-2570.
160. N. L. Urizar, D. H. Dowhan, D. D. Moore: The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275 (2000) 39313-39317.
161. B. A. Laffitte, H. R. Kast, C. M. Nguyen, A. M. Zavacki, D. D. Moore, P. A. Edwards: Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem. 275 (2000) 10638-10647.
162. A. Y. Tu, J. J. Albers: Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene. Biochem. Biophys. Res. Commun. 287 (2001) 921-926.
163. H. R. Kast, C. M. Nguyen, C. J. Sinal, S. A. Jones, B. A. Laffitte, K. Reue, F. J. Gonzalez, T. M. Willson, P. A. Edwards: Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol. Endocrinol. 15 (2001) 1720-1728.
164. W. Lin, H. Wang, C. Sum, D. Liu, C. Hew, B. Chung: Zebrafish ftz-f1 gene has two promoters, is alternatively spliced, and is expressed in digestive organs. Biochem. J. 348 Pt 2 (2000) 439-446.
165. J. D. Tugwood, I. Issemann, S. Green: LRH-1: A nuclear hormone receptor active in the absence of exogenous ligands. GenBank® Nucleotide Sequence Database accession no. M81385 (1991).
166. E. Sablin, I. Krylova, R. Fletterick, H. Ingraham: Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol. Cell 11 (2003) 1575-1585.
167. D. S. Lala, P. M. Syka, S. B. Lazarchik, D. J. Mangelsdorf, K. L. Parker, R. A. Heyman: Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4895-4900.
168. D. W. Russell, K. D. R. Setchell: Bile acid biosynthesis. Biochemistry 31 (1992) 4737-4749.
169. A. del Castillo-Olivares, G. Gil: Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. J. Biol. Chem. 275 (2000) 17793-17799.
170. F. Chen, L. Ma, P. A. Dawson, C. J. Sinal, E. Sehayek, F. J. Gonzalez, J. Breslow, M. Ananthanarayanan, B. L. Shneider: Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J. Biol. Chem. 278 (2003) 19909-19916.
171. A. Inokuchi, E. Hinoshita, Y. Iwamoto, K. Kohno, M. Kuwano, T. Uchiumi: Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J. Biol. Chem. 276 (2001) 46822-46829.
172. S. Tzeng, J. Huang: Transcriptional regulation of the rat Mrp3 promoter in intestine cells. Biochem Biophys. Res. Commun. 291 (2002) 270-277.
173. K. Schoonjans, J. S. Annicotte, T. Huby, O. A. Botrugno, E. Fayard, Y. Ueda, J. Chapman, J. Auwerx: Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep. 3 (2002) 1181-1187.
174. B. Goodwin, S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, P. R. Maloney, T. M. Willson, S. A. Kliewer: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6 (2000) 517-526.
175. G. Francis, E. Fayard, F. Picard, J. Auwerx: Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65 (2003) 261-311.
176. W. Seol, H.-S. Choi, D. D. Moore: An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272 (1996) 1336-1339.
177. L. Johansson, J. S. Thomsen, A. E. Damdimopoulos, G. Spyrou, J.-Å. Gustafsson, E. Treuter: The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERα and ERβ. J. Biol. Chem. 274 (1999) 345-353.
178. Y.-K. Lee, H. Dell, D. H. Dowhan, M. Hadzopoulou-Cladaras, D. D. Moore: The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: Two mechanisms for repression. Mol. Cell. Biol. 20 (2000) 187-195.
179. S. Gupta, R. T. Stravitz, P. Dent, P. B. Hylemon: Down-regulation of cholesterol 7α-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N- terminal kinase pathway. J. Biol. Chem. 276 (2001) 15816-15822.
180. T. Kerr, S. Saeki, M. Schneider, K. Schaefer, S. Berdy, T. Redder, B. Shan, D. Russell, M. Schwarz: Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev. Cell 2 (2002) 713-720.
181. L. J. Borgius, K. R. Steffensen, J.-A. Gustafsson, E. Treuter: Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP. J. Biol. Chem. 277 (2002) 49761-49766.
182. H. Nishigori, H. Tomura, N. Tonooka, M. Kanamori, S. Yamada, K. Sho, I. Inoue, N. Kikuchi, K. Onigata, I. Kojima, T. Kohama, K. Yamagata, Q. Yang, Y. Matsuzawa, T. Miki, S. Seino, M.-Y. Kim, H.-S. Choi, Y-K. Lee, D. D. Moore, J. Takeda: Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 575-580.
183. S. M. S. Mitchell, M. N. Weedon, K. R. Owen, B. Shields, B. Wilkins-Wall, M. Walker, M. I. McCarthy, T. M. Frayling, A. T. Hattersley: Genetic variation in the small heterodimer partner gene and young-onset type 2 diabetes, obesity, and birth weight in U.K. Subjects. Diabetes 52 (2003) 1276-1291.
184. C.-C. C. Hung, I. S. Farooqi, K. Ong, J. A. Luan, J. M. Keogh, M. Pembrey, G. S. H. Yeo, D. Dunger, N. J. Wareham, S. O'Rahilly: Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations. Diabetes 52 (2003) 1288-1291.
185. H. Nishizawa, K. Yamagata, I. Shimomura, M. Takahashi, H. Kuriyama, K. Kishida, K. Hotta, H. Nagaretani, N. Maeda, M. Matsuda, S. Kihara, T. Nakamura, H. Nishigori, H. Tomura, D. D. Moore, J. Takeda, T. Funahashi, Y. Matsuzawa: Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor γ transactivation. J. Biol. Chem. 277 (2002) 1586-1592.
186. Y. S. Kim, C.-Y. Han, S.-W. Kim, J.-H. Kim, S.-K. Lee, D.-J. Jung, S.-Y. Park, H. Kang, H.-S. Choi, J. W. Lee, Y. K. Pak: The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-κB in oxidized low density lipoprotein-treated macrophage cell line RAW 264.7. J. Biol. Chem. 276 (2001) 33736-33740.
187. F. M. Sladek, W. Zhong, E. Lai, J. E. Darnell: Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Gene Dev. 4 (1990) 2353-2365.
188. R. Hertz, J. Magenheim, I. Berman, J. Bar-Tana: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α. Nature 392 (1998) 512-516.
189. A. D. Petrescu, R. Hertz, J. Bar-Tana, F. Schroeder, A. B. Kier: Ligand specificity and conformational dependence of the hepatic nuclear factor-4α (HNF-4α). J. Biol. Chem. 277 (2002) 23988-23999.
190. G. Wisely, A. Miller, R. Davis, A. Thornquest, R. Johnson, T. Spitzer, A. Sefler, B. Shearer, J. Moore, T. Willson, S. Williams: Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure (Camb) 10 (2002) 1225-1234.
191. S. Dhe-Paganon, K. Duda, M. Iwamoto, Y.-I. Chi, S. E. Shoelson: Crystal structure of the HNF4 α ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277 (2002) 37973-37976.
192. T. Naiki, M. Nagaki, Y. Shidoji, H. Kojima, M. Imose, T. Kato, N. Ohishi, K. Yagi, H. Moriwaki: Analysis of gene expression profile induced by hepatocyte nuclear factor 4α in hepatoma cells using an oligonucleotide microarray. J. Biol. Chem. 277 (2002) 14011-14019.
193. G. P. Hayhurst, Y.-H. Lee, G. Lambert, J. M. Ward, F. J. Gonzalez: Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21 (2001) 1393-1403.
194. G. Velho, P. Froguel: Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus. Diabetes Metab. 2 (1997) 34-37.
195. R. Bartoov-Shifman, R. Hertz, H. Wang, C. B. Wollheim, J. Bar-Tana, M. D. Walker: Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4α. J. Biol. Chem. 277 (2002) 25914-25919.
196. S. K. Hansen, M. Parrizas, M. L. Jensen, S. Pruhova, J. Ek, S. F. Boj, A. Johansen, M. A. Maestro, F. Rivera, H. Eiberg, M. Andel, J. Lebl, O. Pedersen, J. Ferrer, T. Hansen: Genetic evidence that HNF-1α-dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. J. Clin. Invest. 110 (2002) 827-833.
197. M. Crestani, A. Sadeghpour, D. Stroup, G. Galli, J. Y. L. Chiang: Transcriptional activation of the cholesterol 7α-hydroxylase gene (CYP7A) by nuclear hormone receptors. J. Lipid Res. 39 (1998) 2192-2200.
198. D. Stroup, J. Y. Chiang: HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7α-hydroxylase gene (CYP7A1). J. Lipid Res. 41 (2000) 1-11.
199. J. C. Wang, P. E. Stromstedt, T. Sugiyama, D. K. Granner: The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 β (hepatic nuclear factor-3 β) and HNF4 and the necessity of proper alignment of their cognate binding sites. Mol. Endocrinol. 13 (1999) 604-618.
200. J. C. Yoon, P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, C. B. Newgard, B. M. Spiegelman: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 (2001) 131-138.
201. S. Herzig, F. Long, U. S. Jhala, S. Hedrick, R. Quinn, A. Bauer, D. Rudolph, G. Schutz, C. Yoon, P. Puigserver, B. Spiegelman, M. Montminy: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 (2001) 179-183.